Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.
about
Active thrombopoiesis is associated with worse severity and activity of chronic GVHD.Thrombopoietic status of patients on haemodialysis.How we treat chronic graft-versus-host disease.Oral disease profiles in chronic graft versus host disease.Oral chronic graft-versus-host disease: current pathogenesis, therapy, and researchValidation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measuresWhich questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease.Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters.Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery.NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.Oral chronic graft-vs.-host disease characterization using the NIH scale.Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease.Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD.Malnutrition in patients with chronic GVHDClinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT.Prevalence of isolated joint involvement in chronic graft-versus-host disease: comment on the article by Inamoto et al.Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications.
P2860
Q33408944-69C1031B-C410-420A-B128-3053FD1221D4Q33430095-7053A4C6-7356-4EEF-9A4E-D09686B29CCDQ35004923-26335A17-E432-4042-8F82-62DAAD65D146Q35796513-8924A5F4-F58B-45ED-8664-95D26C630035Q36579263-9A7CFF12-344A-442F-A757-21D885C9AA57Q36628855-0FF56DC9-EF97-48D5-B9B1-B91D640719C4Q36707816-DCFAD025-6E73-47D6-B946-D30FC9412E8AQ36747224-558B0C65-79B0-4CAD-B589-3D24C20B4EC9Q37075979-DF4D842D-8CAB-4B38-869E-7EB7C810E7E1Q37075990-246A21EB-7B1C-4ACF-B761-8995FE8F07CAQ37076010-15045DF7-4EC9-460E-9B2C-AA0F27BE9A24Q37522548-3A9F96DD-6566-455A-8B3E-A1CFE46CD71FQ39140290-C635A3DC-70C3-4DCA-A2D6-6D50C7003C14Q39550546-7F184BEB-818A-4D5B-A764-537580F0421DQ39818593-EAEF528A-3E7A-4121-AD58-303D304D9D54Q40038510-A071000C-CA26-42AF-815E-D3BC3395A5CFQ41180848-056DA982-0C19-4C90-B7A1-C71801F9AD00Q41180891-F6201A62-8F12-41DF-9179-CEB765A098D0Q41456444-C8B76F40-9ADB-4CD0-B940-0D5280F7BBB4Q42965970-30ABBB61-256A-4AFB-80DE-9018E2B3B1C7Q49645938-B55CE090-0681-4474-9DF3-0FC05683A3CE
P2860
Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Clinical laboratory markers of ...... ivity and NIH global severity.
@ast
Clinical laboratory markers of ...... ivity and NIH global severity.
@en
type
label
Clinical laboratory markers of ...... ivity and NIH global severity.
@ast
Clinical laboratory markers of ...... ivity and NIH global severity.
@en
prefLabel
Clinical laboratory markers of ...... ivity and NIH global severity.
@ast
Clinical laboratory markers of ...... ivity and NIH global severity.
@en
P2093
P2860
P356
P1433
P1476
Clinical laboratory markers of ...... ivity and NIH global severity.
@en
P2093
D H Fowler
K J Martires
K M Williams
P2860
P2888
P304
P356
10.1038/LEU.2011.254
P577
2011-10-18T00:00:00Z
P5875
P6179
1043518583